Echocardiographic predictors of undiagnosed heart failure with preserved ejection fraction in hospitalized atrial fibrillation patients with dyspnea
https://doi.org/10.20538/1682-0363-2025-4-21-30
Abstract
The aim was to evaluate the prevalence and echocardiographic predictors of previously undiagnosed heart failure with preserved ejection fraction (HFpEF) in patients with atrial fibrillation (AF) and chronic dyspnea.
Material and methods. This prospective observational study included 85 patients hospitalized for cardioversion with paroxysmal or persistent AF and chronic dyspnea. All participants underwent transthoracic speckle-tracking echocardiography of left atrial longitudinal strain (LAS). HFpEF probability was assessed using the HFA-PEFF algorithm. Dynamic follow-up of diastolic function was performed at three predefined time points: during AF paroxysm, 24 hours post-cardioversion, and one-month post-cardioversion.
Results. High probability of HFpEF was identified in 78.7% of patients (67 out of 85). These patients exhibited significantly higher NT-proBNP levels, greater CHA₂DS₂-VASc score, as well as more impaired LAS parameters and elevated left atrial stiffness index compared to low-intermediate HFpEF probability groups. At one-month follow-up after cardioversion (n = 55), while NT-proBNP levels significantly declined, overall HFpEF probability remained unchanged. Left atrial stiffness index demonstrated the strongest independent predictive value in verifying high probability HFpEF, with remarkable discriminative capacity both during AF (OR = 34.5; 95% CI 2.5–478.7) and after sinus rhythm restoration (OR = 193.1; 95% CI 7.3–1,207).
Conclusion. This study reveals high prevalence of undiagnosed HFpEF among AF patients undergoing cardioversion, with disease probability persisting despite rhythm control during one-month follow-up. The left atrial stiffness index is as a valuable diagnostic marker for HFpEF detection in this population, potentially enhancing standard HFA-PEFF algorithm.
About the Authors
M. A. DavletovaRussian Federation
6 Miklouho-Maclay St., 117198 Moscow
Y. V. Stavtseva
Russian Federation
6 Miklouho-Maclay St., 117198 Moscow,
61 Vavilov St., 117292 Moscow
A. F. Safarova
Russian Federation
6 Miklouho-Maclay St., 117198 Moscow
T. M. Timofeeva
Russian Federation
6 Miklouho-Maclay St., 117198 Moscow,
61 Vavilov St., 117292 Moscow
Zh. D. Kobalava
Russian Federation
6 Miklouho-Maclay St., 117198 Moscow
References
1. Reddy Y.N.V., Carter R.E., Obokata M., Redfield M.M., Borlaug B.A. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 201828;138(9):861–870. DOI: 10.1161/CIRCULATIONAHA.118.034646.
2. Pieske B., Tschöpe C., de Boer R.A., Fraser A.G., Anker S.D., Donal E. et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur. Heart J. 201921;40(40):3297–3317. DOI: 10.1093/eurheartj/ehz641.
3. Thomas L., Marwick T.H., Popescu B.A., Donal E., Badano L.P. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction: JACC State-of-the-Art Review. J. Am. Coll. Cardiol. 201923;73(15):1961–1977. DOI: 10.1016/j.jacc.2019.01.059.
4. Cleland J.G.F., Lyon A.R., McDonagh T., McMurray J.J.V. The year in cardiology: heart failure. Eur. Heart J. 2020;41(12):1232–1248. DOI: 10.1093/eurheartj/ehz949.
5. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S. et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J. 2016;37(27):2129–2200. DOI: 10.1093/eurheartj/ehw128.
6. Reddy Y.N.V., Obokata M., Egbe A., Yang J.H., Pislaru S., Lin G. et al. Left atrial strain and compliance in the diagnostic evaluation of heart failure with preserved ejection fraction. Eur. J. Heart Fail. 2019;21(7):891–900. DOI: 10.1002/ejhf.1464.
7. Carlisle M.A., Fudim M., DeVore A.D., Piccini J.P. Heart failure and atrial fibrillation, like fire and fury. JACC Heart Fail. 2019;7(6):447–456. DOI: 10.1016/j.jchf.2019.03.005.
8. Sugumar H., Nanayakkara S., Prabhu S., Voskoboinik A., Kaye D.M., Ling L.H. et al. Pathophysiology of atrial fibrillation and heart failure: dangerous interactions. Cardiol. Clin. 2019;37(2):131–138. DOI: 10.1016/j.ccl.2019.01.002.
9. Bisbal F., Baranchuk A., Braunwald E., Bayés de Luna A., Bayés-Genís A. Atrial Failure as a Clinical Entity: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 202021;75(2):222– 232. DOI: 10.1016/j.jacc.2019.11.013.
10. Patel R.B., Alenezi F., Sun J.L., Alhanti B., Vaduganathan M., Oh J.K. et al. Biomarker Profile of Left Atrial Myopathy in Heart Failure With Preserved Ejection Fraction: Insights From the RELAX Trial. J. Card. Fail. 2020;26(3):270–275. DOI: 10.1016/j.cardfail.2019.12.001.
11. Галявич А.С., Терещенко С.Н., Ускач Т.М., Агеев Ф.Т., Аронов Д.М., Арутюнов Г.П. и др. Хроническая сердечная недостаточность. Клинические рекомендации 2024. Российский кардиологический журнал. 2024;29(11):6162. DOI: 10.15829/1560-4071-2024-6162.
12. McDonagh T.A., Metra M., Adamo M., Gardner R.S., Baumbach A., Böhm M. et al. ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 2021;42(36):3599– 3726. DOI: 10.1093/eurheartj/ehab368.
13. Singh A., Addetia K., Maffessanti F., Mor-Avi V., Lang R.M. LA strain for categorization of LV diastolic dysfunction. JACC Cardiovasc. Imaging. 2017;10(7):735–743. DOI: 10.1016/j.jcmg.2016.08.014.
14. Reddy Y.N.V., Borlaug B.A., O’Connor C.M., Gersh B.J. Novel approaches to the management of chronic systolic heart failure: future directions and unanswered questions. Eur. Heart J. 2020;41(18):1764–1774. DOI: 10.1093/eurheartj/ehz364.
15. Kurt M., Wang J., Torre-Amione G., Nagueh S.F. Left atrial function in diastolic heart failure. Circ. Cardiovasc. Imaging. 2009;2(1):10–15. DOI: 10.1161/CIRCIMAGING.108.813071.
16. Obokata M., Negishi K., Kurosawa K., Arima H., Tateno R., Ui G. et al. Incremental diagnostic value of la strain with leg lifts in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging. 2013;6(7):749–758. DOI: 10.1016/j.jcmg.2013.04.006.
17. Badano L.P., Kolias T.J., Muraru D., Abraham T.P., Aurigemma G., Edvardsen T. et al. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. Eur. Heart J. Cardiovasc. Imaging. 2018;19(6):591–600. DOI: 10.1093/ehjci/jey042.
18. Nauta J.F., Hummel Y.M., van der Meer P., Lam C.S.P., Voors A.A., van Melle J.P. Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fraction. Eur. J. Heart Fail. 2018;20(9):1303–1311. DOI: 10.1002/ejhf.1220.
19. Овчинников А.Г., Агеев Ф.Т., Алёхин М.Н., Беленков Ю.Н., Васюк Ю.А., Галявич А.С. и др. Диастолическая трансторакальная стресс-эхокардиография с дозированной физической нагрузкой в диагностике сердечной недостаточности с сохраненной фракцией выброса: показания, методология, интерпретация результатов Согласованное мнение экспертов, выработанное под эгидой ФГБУ «Национальный медицинский исследовательский центр кардиологии» МЗ РФ, Общества специалистов по сердечной недостаточности (ОССН) и Российской ассоциации специалистов ультразвуковой диагностики в медицине (РАСУДМ). Кардиология. 2020;60(12):48–63. DOI: 10.18087/cardio.2020.12.n1219.
20. Naser J.A., Lee E., Scott C.G., Kennedy A.M., Pellikka P.A., Lin G., Pislaru S.V. et al. Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications. Eur. Heart J. 2023;44(48):5049–5060. DOI: 10.1093/eurheartj/ehad592.
21. Reddy Y.N.V., Obokata M., Gersh B.J., Borlaug B.A. High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea. Circulation. 201830;137(5):534–535. DOI: 10.1161/CIRCULATIONAHA.117.030093.
22. Sugumar H., Nanayakkara S., Vizi D., Wright L., Chieng D., Leet A. et al. A prospective STudy using invAsive haemodynamic measurements foLLowing catheter ablation for AF and early HFpEF: STALL AF-HFpEF. Eur. J. Heart Fail. 2021;23(5):785–796. DOI: 10.1002/ejhf.2122.
23. Chieng D., Sugumar H., Segan L., Tan C., Vizi D., Nanayakkara S. et al. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: A Randomized Controlled Trial. JACC Heart Fail. 2023;11(6):646–658. DOI: 10.1016/j.jchf.2023.01.008.
24. Reddy Y.N.V., Noseworthy P., Borlaug B.A., Albert N.M. Screening for unrecognized HFpEF in atrial fibrillation and for unrecognized atrial fibrillation in HFpEF. JACC Heart Fail. 2024;12(6):990–998. DOI: 10.1016/j.jchf.2024.04.010.
25. Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю., Голицын С.П., Голухова Е.З., Горев М.В., и др. Фибрилляция и трепетание предсердий. Клинические рекомендации 2020. Российский кардиологический журнал. 2021;26(7):4594. DOI: 10.15829/1560-4071-2021-4594.
26. Kittipibul V., Lam C.S.P. Heart failure with preserved ejection fraction and atrial fibrillation: epidemiology, pathophysiology, and diagnosis interplay. Heart Fail Rev. 2025. DOI: 10.1007/s10741-025-10488-0.
27. Von Roeder M., Blazek S., Rommel K.P., Kresoja K.P., Gioia G., Mentzel L. et al. Changes in left atrial function in patients undergoing cardioversion for atrial fibrillation: relevance of left atrial strain in heart failure. Clin. Res. Cardiol. 2022;111(9):1028–1039. DOI: 10.1007/s00392-021-01982-0.
28. Sonaglioni A., Nicolosi G.L., Bruno A., Lombardo M., Muti P. Echocardiographic Assessment of Left Atrial Mechanics in Patients with Atrial Fibrillation Undergoing Electrical Cardioversion: A Systematic Review. J. Clin. Med. 2024;13(21):6296. DOI: 10.3390/jcm13216296.
29. Soulat-Dufour L., Lang S., Ederhy S., Ancedy Y., Beraud A.S., Adavane-Scheuble S. et al. Biatrial remodelling in atrial fibrillation: A three-dimensional and strain echocardiography insight. Arch. Cardiovasc. Dis. 2019;112(10):585– 593. DOI: 10.1016/j.acvd.2019.06.010.
30. Dell’Era G., Rondano E., Franchi E., Marino P.N. Novara Atrial Fibrillation (NAIF) Study Group. Atrial asynchrony and function before and after electrical cardioversion for persistent atrial fibrillation. Eur. J. Echocardiogr. 2010;11(7):577–583. DOI: 10.1093/ejechocard/jeq010.
31. Shaikh A.Y., Maan A., Khan U.A., Aurigemma G.P., Hill J.C., Kane J.L. et al. Speckle echocardiographic left atrial strain and stiffness index as predictors of maintenance of sinus rhythm after cardioversion for atrial fibrillation: a prospective study. Cardiovasc. Ultrasound. 2012;10:48. DOI: 10.1186/1476-7120-10-48.
32. Schneider C., Malisius R., Krause K., Lampe F., Bahlmann E., Boczor S. et al. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur. Heart J. 2008;29(11):1397–1409. DOI: 10.1093/eurheartj/ehn168.
33. Thomas L., McKay T., Byth K., Marwick T.H. Abnormalities of left atrial function after cardioversion: an atrial strain rate study. Heart. 2007;93(1):89–95. DOI: 10.1136/hrt.2006.088609.
34. Kirchhof P., Camm A.J., Goette A., Brandes A., Eckardt L., Elvan A. et al. EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N. Engl. J. Med. 2020;383(14):1305–1316. DOI: 10.1056/NEJMoa2019422.
35. Machino-Ohtsuka T., Seo Y., Tada H., Ishizu T., Machino T., Yamasaki H. et al. Left atrial stiffness relates to left ventricular diastolic dysfunction and recurrence after pulmonary vein isolation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 2011;22(9):999–1006. DOI: 10.1111/j.1540-8167.2011.02049.x.
36. Khurram I.M., Maqbool F., Berger R.D., Marine J.E., Spragg D.D., Ashikaga H. et al. Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation. Circ. Arrhythm. Electrophysiol. 2016;9(3):e003163. DOI: 10.1161/CIRCEP.115.003163.
37. Kim D., Seo J.H., Choi K.H., Lee S.H., Choi J.O., Jeon E.S. et al. Prognostic implications of left atrial stiffness index in heart failure patients with preserved ejection fraction. JACC Cardiovasc. Imaging. 2023;16(4):435–445. DOI: 10.1016/j.jcmg.2022.11.002.
38. Zhu S., Lin Y., Zhang Y., Wang G., Qian M., Gao L. et al. Prognostic relevance of left atrial function and stiffness in heart failure with preserved ejection fraction patients with and without diabetes mellitus. Front. Cardiovasc. Med. 2022;9:947639. DOI: 10.3389/fcvm.2022.947639.
39. Reddy Y.N.V., Obokata M., Verbrugge F.H., Lin G., Borlaug B.A. Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation. J. Am. Coll. Cardiol. 2020;76(9):1051–1064. DOI: 10.1016/j.jacc.2020.07.009.
40. Ma C.S., Liao Y.P., Fan J.L., Zhao X., Su B., Zhou B.Y. The novel left atrial strain parameters in diagnosing of heart failure with preserved ejection fraction. Echocardiography. 2022;39(3):416–425. DOI: 10.1111/echo.15304.
41. Rimbas R.C., Visoiu I.S., Magda S.L., Mihaila-Baldea S., Luchian M.L., Chitroceanu A.M. et al. New insights into the potential utility of the left atrial function analysis in heart failure with preserved ejection fraction diagnosis. PLoS One. 2022;17(5):e0267962. DOI: 10.1371/journal.pone.0267962.
42. Di Salvo G., Caso P., Lo Piccolo R., Fusco A., Martiniello A.R., Russo M.G. et al. Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation. 2005;112(3):387–395. DOI: 10.1161/CIRCULATIONAHA.104.463125.
Review
For citations:
Davletova M.A., Stavtseva Y.V., Safarova A.F., Timofeeva T.M., Kobalava Zh.D. Echocardiographic predictors of undiagnosed heart failure with preserved ejection fraction in hospitalized atrial fibrillation patients with dyspnea. Bulletin of Siberian Medicine. 2025;24(4):21-30. (In Russ.) https://doi.org/10.20538/1682-0363-2025-4-21-30
JATS XML









































